Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Abigail M, Garner"'
Autor:
Jan B Pietzsch, Benjamin P Geisler, Abigail M Garner, Anne M Ryschon, William A Gray, Masahiko Fujihara, Peter A Schneider
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 14, Iss 1 (2024)
Aim: Percutaneous transluminal angioplasty (PTA) for peripheral artery disease (PAD) commonly leads to dissections which are associated with higher target lesion revascularization (TLR) rates. Clinical and economic consequences of dissection manage
Externí odkaz:
https://doaj.org/article/31cab84838b84a60bd17d433dd3b49c1
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 3, Iss 1 (2015)
**Background:** High flow therapy (HFT) has been demonstrated to be a safe and effective noninvasive respiratory support technique for the treatment of pre-term infants in neonatal intensive care. **Objectives:** Our objective was to develop a quant
Externí odkaz:
https://doaj.org/article/6410cfef589e409981891372dcd533d2
Autor:
Abigail M. Garner, Shan Liu, Jan B. Pietzsch, Scott C. Faucett, Benjamin P. Geisler, Aaron J. Krych, Jorge Chahla, Peter R. Kurzweil, Robert F. LaPrade
Publikováno v:
The American Journal of Sports Medicine. 47:762-769
Background:Medial meniscus root tears are a common knee injury and can lead to accelerated osteoarthritis, which might ultimately result in a total knee replacement.Purpose:To compare meniscus repair, meniscectomy, and nonoperative treatment approach
Publikováno v:
The Knee. 23:674-680
Background Meniscal tears are the most common knee condition requiring surgery, and represent a substantial disease burden with clinical and cost implications. The success rates partial meniscectomy and meniscal repair have been studied, but limited
Autor:
Jan B. Pietzsch, Shan Liu, Karen Noblett, Roger R. Dmochowski, Sandip P. Vasavada, Abigail M. Garner
Publikováno v:
Neurourology and Urodynamics. 36:727-733
Objectives Sacral neuromodulation (SNM) is a guideline-recommended third-line treatment option for managing overactive bladder. Current SNM devices are not rechargeable, and require neurostimulator replacement every 3-6 years. Our study objective was
Publikováno v:
Sleep. 38:735-744
Study objectives Upper airway stimulation (UAS) is a new approach to treat moderate-to-severe obstructive sleep apnea. Recently, 12-month data from the Stimulation Treatment for Apnea Reduction (STAR) trial were reported, evaluating the effectiveness
Publikováno v:
Catheterization and Cardiovascular Interventions. 84:546-554
Objectives To study the economic impact on payers and providers of the four main endovascular strategies for the treatment of infrainguinal peripheral artery disease. Background Bare metal stents (BMS), drug-eluting stents (DES), and drug-coated ball
Autor:
Konstantinos Katsanos, Trevor Cleveland, Hany Zayed, Jan B. Pietzsch, Benjamin P. Geisler, Abigail M. Garner
Publikováno v:
BMJ Open
Objectives To estimate the clinical and economic impact of drug-eluting endovascular treatment strategies for femoropopliteal artery disease compared with current standard of care. Design Systematic literature search to pool target lesion revasculari
Publikováno v:
Neuromodulation : journal of the International Neuromodulation Society. 19(7)
Objectives Deep brain stimulation (DBS), which uses an implantable device to modulate brain activity, is clinically superior to medical therapy for treating advanced Parkinson's disease (PD). We studied the cost-effectiveness of DBS in conjunction wi
Autor:
Karen L, Noblett, Roger R, Dmochowski, Sandip P, Vasavada, Abigail M, Garner, Shan, Liu, Jan B, Pietzsch
Publikováno v:
Neurourology and urodynamics. 36(3)
Sacral neuromodulation (SNM) is a guideline-recommended third-line treatment option for managing overactive bladder. Current SNM devices are not rechargeable, and require neurostimulator replacement every 3-6 years. Our study objective was to assess